Dietary nutrients show mixed results for brain diseases in lab and early human data

People living with Alzheimer's disease, Parkinson's disease, multiple sclerosis, or amyotrophic lateral sclerosis often wonder if diet can help. They hope that vitamins, minerals, and compounds from plants or the ocean might slow their condition. A recent review looked at this hope carefully. It examined nutrients like polyunsaturated fatty acids and newer metabolites from marine sources and the microbiome. These are substances our bodies make or get from food. The review found that while these nutrients work well in test tubes and animal models, the picture for humans is different. Translating lab success to real patient benefit remains inconsistent. The study involved many different research designs. This variety made it hard to compare results directly. Scientists also noted issues with how well these nutrients are absorbed by the body. Some struggle to cross the blood-brain barrier, which protects the brain but blocks many helpful substances. Dosing strategies varied widely across the studies reviewed. The review did not report specific safety events or side effects. However, the uncertainty about how these nutrients work in people is significant. We cannot yet say if eating these nutrients will change outcomes for patients. The current evidence is not strong enough to make firm recommendations.